Opioid use and stigma: The role of gender, language and precipitating events K Goodyear, CL Haass-Koffler, D Chavanne Drug and alcohol dependence 185, 339-346, 2018 | 185 | 2018 |
Pharmacological approaches to reducing craving in patients with alcohol use disorders CL Haass-Koffler, L Leggio, GA Kenna CNS drugs 28, 343-360, 2014 | 108 | 2014 |
Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking JA Simms, CL Haass-Koffler, J Bito-Onon, R Li, SE Bartlett Neuropsychopharmacology 37 (4), 906-918, 2012 | 102 | 2012 |
Role of the α1 blocker doxazosin in alcoholism: a proof‐of‐concept randomized controlled trial GA Kenna, CL Haass‐Koffler, WH Zywiak, SM Edwards, MB Brickley, ... Addiction biology 21 (4), 904-914, 2016 | 70 | 2016 |
Pharmacotherapy for alcoholic patients with alcoholic liver disease CL Vuittonet, M Halse, L Leggio, SB Fricchione, M Brickley, ... American journal of health-system pharmacy 71 (15), 1265-1276, 2014 | 69 | 2014 |
Noradrenergic targets for the treatment of alcohol use disorder CL Haass-Koffler, RM Swift, L Leggio Psychopharmacology 235, 1625-1634, 2018 | 68 | 2018 |
Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity CL Haass-Koffler, SE Bartlett Frontiers in molecular neuroscience 5, 91, 2012 | 64 | 2012 |
The α5 subunit regulates the expression and function of α4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental area S Chatterjee, N Santos, J Holgate, CL Haass-Koffler, FW Hopf, V Kharazia, ... PloS one 8 (7), e68300, 2013 | 52 | 2013 |
Ondansetron Reduces Naturalistic Drinking in Nontreatment‐Seeking Alcohol‐Dependent Individuals with the LL 5′‐HTTLPR Genotype: A Laboratory Study GA Kenna, WH Zywiak, RM Swift, JE McGeary, JS Clifford, JR Shoaff, ... Alcoholism: Clinical and Experimental Research 38 (6), 1567-1574, 2014 | 48 | 2014 |
Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin CL Haass-Koffler, K Goodyear, WH Zywiak, M Magill, SE Eltinge, ... Drug and alcohol dependence 177, 23-28, 2017 | 43 | 2017 |
A relationship between the aldosterone–mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans EG Aoun, VA Jimenez, LF Vendruscolo, NAR Walter, E Barbier, A Ferrulli, ... Molecular psychiatry 23 (6), 1466-1473, 2018 | 42 | 2018 |
Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving CL Haass-Koffler, EG Aoun, RM Swift, SM De La Monte, GA Kenna, ... Translational psychiatry 5 (9), e646-e646, 2015 | 40 | 2015 |
Defining the role of corticotropin releasing factor binding protein in alcohol consumption CL Haass-Koffler, AT Henry, G Melkus, JA Simms, M Naemmuddin, ... Translational psychiatry 6 (11), e953-e953, 2016 | 37 | 2016 |
Comparing and combining topiramate and aripiprazole on alcohol-related outcomes in a human laboratory study CL Haass-Koffler, K Goodyear, WH Zywiak, L Leggio, GA Kenna, ... Alcohol and Alcoholism 53 (3), 268-276, 2018 | 26 | 2018 |
An analytical tool that quantifies cellular morphology changes from three-dimensional fluorescence images CL Haass-Koffler, M Naeemuddin, SE Bartlett JoVE (Journal of Visualized Experiments), e4233, 2012 | 26 | 2012 |
Relationship between the thyroid axis and alcohol craving EG Aoun, MR Lee, CL Haass-Koffler, RM Swift, G Addolorato, GA Kenna, ... Alcohol and alcoholism 50 (1), 24-29, 2015 | 23 | 2015 |
The amygdala noradrenergic system is compromised with alcohol use disorder FP Varodayan, RR Patel, A Matzeu, SA Wolfe, DE Curley, S Khom, ... Biological psychiatry 91 (12), 1008-1018, 2022 | 22 | 2022 |
Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings GA Kenna, WH Zywiak, RM Swift, JE McGeary, JS Clifford, JR Shoaff, ... Alcohol 48 (6), 515-522, 2014 | 22 | 2014 |
A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and … CL Haass-Koffler, K Goodyear, VM Long, HH Tran, A Loche, R Cacciaglia, ... European Journal of Pharmaceutical Sciences 109, 78-85, 2017 | 20 | 2017 |
Serum insulin levels are reduced by intravenous ghrelin administration but do not correlate with alcohol craving in alcohol-dependent individuals CL Haass-Koffler, DE Giovenco, MR Lee, WH Zywiak, SM De la Monte, ... International Journal of Neuropsychopharmacology 19 (10), pyw048, 2016 | 18 | 2016 |